R. Geoffrey Sargent
Fondatore presso GENETETHER THERAPEUTICS INC.
Patrimonio netto: 19 375 $ in data 31/05/2024
Profilo
Dr. R.
G.
Sargent is a Chief Scientific Officer at GeneTether Therapeutics, Inc. and a Director & Chief Scientific Officer at GeneTether, Inc. He is on the Board of Directors at GeneTether, Inc. Dr. Sargent was previously employed as a Chief Scientific Officer by Onconetics Pharmaceuticals, Inc. He received his undergraduate degree from Georgia Institute of Technology and a doctorate degree from Oregon State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 18/10/2023 | 775 000 ( 2.00% ) | 19 375 $ | 31/05/2024 |
Posizioni attive di R. Geoffrey Sargent
| Società | Posizione | Inizio |
|---|---|---|
| GENETETHER THERAPEUTICS INC. | Fondatore | 12/02/2018 |
GeneTether, Inc.
 GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Fondatore | 12/02/2018 |
Precedenti posizioni note di R. Geoffrey Sargent
| Società | Posizione | Fine |
|---|---|---|
Onconetics Pharmaceuticals, Inc.
 Onconetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onconetics Pharmaceuticals, Inc. develops personalized gene therapies for cancers and other genetic disorders. The company was founded by Luke Gruenert and Gabriel Hitchcock and is headquartered in mill valley, CA. | Direttore Tecnico/Scientifico/R&S | 01/03/2018 |
Formazione di R. Geoffrey Sargent
| Georgia Institute of Technology | Undergraduate Degree |
| Oregon State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Onconetics Pharmaceuticals, Inc.
Onconetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onconetics Pharmaceuticals, Inc. develops personalized gene therapies for cancers and other genetic disorders. The company was founded by Luke Gruenert and Gabriel Hitchcock and is headquartered in mill valley, CA. | Health Technology |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Commercial Services |
| GeneTether Therapeutics, Inc. |
- Borsa valori
- Insiders
- R. Geoffrey Sargent
